Noxiptylin and masked depression

E. Sacchetti, E. Smeraldi, L. Bellodi, S. Bottinelli, C. Altamura

Research output: Contribution to journalArticlepeer-review

Abstract

An open trial was undertaken to verify the effectiveness of low doses of Noxiptylin (30 mg per day for 30 days) in treatment of episodes of masked depression in a homogeneous cluster of patients (22 subjects) previously diagnosed as primary depressed. Coefficients of regression for intensity of the selected HAMILTON scores over the period of treatment indicate a decrease of the symptoms with time. The analysis shows that the greatest effect of the treatment on the symptoms appeared during the first 8 days.

Original languageEnglish
Pages (from-to)59-63
Number of pages5
JournalAgressologie
Volume19
Issue number1
Publication statusPublished - 1978

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'Noxiptylin and masked depression'. Together they form a unique fingerprint.

Cite this